ADMA Biologics/ US0008991046 /
17/06/2024 21:59:55 | Var. -0.18 | Volume | Denaro- | Lettera- | Max | Min |
---|---|---|---|---|---|---|
10.46USD | -1.65% | 38,500 Fatturato: 403,464.22 |
-Quantità in denaro: - | -Quantità in lettera: - | 10.62 | 10.36 |
Newsfile Corp
11:35
St Kitts and Nevis Government Strengthens the Citizenship by Investment Programme Through Introducti...
GlobeNewswire
11:00
Hydrogen Powered Internal Combustion Engines are the Focus of a Live Webinar & White Paper
GlobeNewswire
11:00
Altus Formulation and Spektar Join Forces in New Specialty Company Spektus Pharma
GlobeNewswire
11:00
Future Health Index 2024 global report: Healthcare leaders turn to AI to address critical gaps in pa...
GlobeNewswire
10:30
Flash News: OKX Lists ZKsync's ZK Token on its Perpetual Futures Market, Expanding Trading Options
GlobeNewswire
10:01
Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD ...
GlobeNewswire
10:00
VSTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Vestis Corporation Investors w...
GlobeNewswire
10:00
FSLY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fastly, Inc. Investors with Su...
GlobeNewswire
10:00
HRBR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Harbor Diversified, Inc. Inves...
GlobeNewswire
10:00
AXTI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AXT Inc Investors with Substan...
GlobeNewswire
10:00
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with ...